Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  New England Journal of Medicine

• Publication date

  1996-04-04

• Fields of study

  Medicine

• Identifiers
  DOI 10.1056/NEJM199604043341402PMID 8596570
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Recurrence of focal segmental glomerulosclerosis in transplanted kidneys: Analysis of incidence and risk factors in 59 allografts

  2004cited by this paper
• C5b-9 increases albumin permeability of isolated glomeruli in vitro.

  1994cited by this paper
• Polymorphonuclear leukocytes increase glomerular albumin permeability via hypohalous acid.

  1994cited by this paper
• Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis.

  1994cited by this paper
• Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome

  1994cited by this paper
• Effect of superoxide exposure on albumin permeability of isolated rat glomeruli.

  1993cited by this paper
• Mechanisms of proteinuria in noninflammatory glomerular diseases.

  1993cited by this paper
• Recurrent nephrotic syndrome after transplantation: Early treatment with plasmaphaeresis and cyclophosphamide

  1993cited by this paper
• Treatment of childhood nephrotic syndrome.

  1992cited by this paper
• Measurement of albumin reflection coefficient with isolated rat glomeruli.

  1992cited by this paper
• Recurrent focal glomerulosclerosis: natural history and response to therapy.

  1992cited by this paper
• Racial differences in the incidence and renal outcome of idiopathic focal segmental glomerulosclerosis in children

  1991cited by this paper
• Incidence, treatment, and outcome of recurrent focal segmental glomerulosclerosis posttransplantation in 42 allografts in children--a single-center experience.

  1991cited by this paper
• A glomerular permeability factor produced by human T cell hybridomas.

  1991cited by this paper
• Membranous nephropathy in renal allograft recipients: A report of 11 cases

  1991cited by this paper
• Increase in proteinuria and reduction in number of anionic sites on the glomerular basement membrane in rabbits by infusion of human nephrotic plasma in vivo.

  1989cited by this paper
• Ciclosporin-induced partial and transient improvement of nephrotic syndrome in recurrent focal segmental glomerulosclerosis.

  1989cited by this paper
• Studies of a glomerular permeability factor in patients with minimal-change nephrotic syndrome.

  1989cited by this paper
• Clinical and histological sequence of recurrent focal segmental glomerulosclerosis.

  1988cited by this paper
• Cyclosporine-induced remission of relapsing nephrotic syndrome in children.

  1988cited by this paper
• Plasma exchange for recurrent nephrotic syndrome following renal transplantation.

  1988cited by this paper
• Epidemiology of idiopathic glomerular disease: a prospective study.

  1987cited by this paper
• Cyclosporine A induced remission of relapsing nephrotic syndrome in children.

  1987cited by this paper
• Paucity of minimal-change lesion in children with early frequently relapsing steroid-responsive nephrotic syndrome.

  1987cited by this paper
• MONONUCLEAR BLOOD-CELLS FROM PATIENTS WITH MINIMAL CHANGE NEPHROTIC SYNDROME (MCNS) INDUCE INCREASED GLOMERULAR-PERMEABILITY IN THE RAT-KIDNEY INVIVO

  1986cited by this paper
• Recurrent focal segmental glomerulosclerosis. A pathological study of the early lesion.

  1986cited by this paper
• The vascular permeability factor is a T lymphocyte product.

  1986cited by this paper
• Plasmapheresis and dipyridamole for recurrent focal glomerular sclerosis.

  1985cited by this paper
• Studies of vascular permeability factor derived from T lymphocytes and inhibitory effect of plasma on its production in minimal change nephrotic syndrome.

  1985cited by this paper
• Increased urinary protein excretion in the rat produced by serum from a patient with recurrent focal glomerular sclerosis after renal transplantation.

  1984cited by this paper
• Increased urinary protein excretion in the rat produced by serum from a patient with recurrent focal glomerular sclerosis after renal transplantation.

  1984cited by this paper
• Changes in the glomerular capillary wall induced by lymphocyte products and serum of nephrotic patients.

  1983cited by this paper
• Recurrent focal sclerosis after renal transplantation.

  1982cited by this paper
• Recurrent focal sclerosis after renal transplantation.

  1982cited by this paper
• The nature of the glomerular injury in minimal change and focal sclerosing glomerulopathies.

  1981cited by this paper
• Filtration in single isolated mammalian glomeruli.

  1981cited by this paper
• Sex maturity ratings.

  1979cited by this paper
• Focal glomerulosclerosis and renal transplantation.

  1979cited by this paper
• A vascular permeability factor in lymphocyte culture supernants from patients with nephrotic syndrome. II. Pharmacological and physicochemical properties.

  1975cited by this paper
• Recurrence of idiopathic nephrotic syndrome after renal transplantation.

  1972cited by this paper

• Advances in Focal Segmental Glomerulosclerosis Treatment From the Perspective of the Newest Mechanisms of Podocyte Injury

  2025cites this paper
• Pathogenesis of Focal Segmental Glomerulosclerosis and Related Disorders

  2025cites this paper
• Circulating anti-nephrin antibody as permeability factor for inducing primary focal segmental glomerular sclerosis and minimal change disease

  2025cites this paper
• Post-Transplant Recurrence of Focal Segmental Glomerulosclerosis: Circulating Factors, Molecular Biomarkers, and Treatments

  2025influential citation
• Trehalose alleviates nephropathy in focal segmental glomerulosclerosis via the upregulation of the WT-1/EZH2 pathway

  2025cites this paper
• Kidney immunology from pathophysiology to clinical translation

  2025cites this paper
• Recurrence of Glomerular Diseases (GN) After Kidney Transplantation: A Narrative Review

  2025cites this paper
• Past and future in vitro and in vivo approaches toward circulating factors and biomarkers in idiopathic nephrotic syndrome

  2025cites this paper
• Serum Factors in Primary Podocytopathies

  2025cites this paper
• CLCF1 contributes to high-glucose-induced EndMT by modulating JAK2/STAT3 signaling

  2025cites this paper
• Dysregulated Anaerobic Glycolysis in Podocytes is Relevant to the Progression of Focal Segmental Glomerulosclerosis

  2025cites this paper
• Autosomal dominant focal segmental glomerulosclerosis by INF2 p.Arg218Trp and p.Ser186Pro mutations: three case reports and literature review

  2025cites this paper
• Podocytopathies (Minimal Change Disease, Focal Segmental Glomerulosclerosis, and Idiopathic Nephrotic Syndrome of Childhood)

  2025cites this paper
• A Comprehensive Look at Focal Segmental Glomerulosclerosis Recurrence in Adult Transplant Patients: Findings from a Single Institution with Review of Literature

  2025cites this paper
• Role of the Innate Immune Response in Glomerular Disease Pathogenesis: Focus on Podocytes

  2024cites this paper
• Podocyte-targeted therapies — progress and future directions

  2024cites this paper
• Multiple-target Therapy for Posttransplant Focal Segmental Glomerulosclerosis

  2024cites this paper
• Potential biomarkers of recurrent FSGS: a review

  2024cites this paper
• Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children.

  2024cites this paper
• Renal survival and treatment of adult patients with Primary Focal Segmental glomerulosclerosis: A historical cohort study of the National Greek Registry

  2024cites this paper
• Rationale and Design of a Phase 2, Double-blind, Placebo-Controlled, Randomized Trial Evaluating AMP Kinase-Activation by Metformin in Focal Segmental Glomerulosclerosis

  2024cites this paper
• A randomized controlled trial of preemptive rituximab to prevent recurrent focal segmental glomerulosclerosis post-kidney transplant (PRI-VENT FSGS): protocol and study design

  2023cites this paper
• Current understanding of the molecular mechanisms of circulating permeability factor in focal segmental glomerulosclerosis

  2023cites this paper
• Bone marrow from focal segmental glomerulosclerosis displays activation of inflammatory pathway.

  2023cites this paper
• State of the art in childhood nephrotic syndrome: concrete discoveries and unmet needs

  2023cites this paper
• Efficacy of extracorporeal plasma therapy for adult native kidney patients with Primary FSGS: a Systematic review

  2023cites this paper
• Successful global anti‐B‐cell strategy with daratumumab in a patient with post‐transplant nephrotic syndrome recurrence unresponsive to immunoadsorption and obinutuzumab

  2023cites this paper
• Preliminary study of anti-CD40 and ubiquitin proteasome antibodies in primary podocytopaties

  2023cites this paper
• A pilot study of anti‐nephrin antibodies in podocytopaties among adults

  2023cites this paper
• Diagnostik und Therapie der Fokal-Segmentalen Glomerulosklerose – 2023

  2023cites this paper
• The View of Pediatric Nephrotic Syndrome as a Podocytopathy

  2023cites this paper
• Post-operative recurrence of focal segmental glomerulosclerosis according to pre-transplant treatment after kidney transplantation

  2023cites this paper
• The Immune System and Idiopathic Nephrotic Syndrome.

  2022cites this paper
• suPAR: An Inflammatory Mediator for Kidneys

  2022cites this paper
• Prostanoid receptors in hyperfiltration‐mediated glomerular injury: Novel agonists and antagonists reveal opposing roles for EP2 and EP4 receptors

  2022cites this paper
• Bioinformatic Analysis Combined With Experimental Validation Reveals Novel Hub Genes and Pathways Associated With Focal Segmental Glomerulosclerosis

  2022cites this paper
• Novel mouse strains to study circulating permeability factor(s) in primary focal segmental glomerulosclerosis

  2022cites this paper
• Integrated genomic, transcriptomic and metabolomic analysis reveals MDH2 mutation-induced metabolic disorder in recurrent focal segmental glomerulosclerosis

  2022cites this paper
• Perturbations in podocyte transcriptome and biological pathways induced by FSGS associated circulating factors

  2022cites this paper
• A critical re-analysis of cases of post-transplantation recurrence in genetic nephrotic syndrome

  2021cites this paper
• Transcription Factor β-Catenin Plays a Key Role in Fluid Flow Shear Stress-Mediated Glomerular Injury in Solitary Kidney

  2021cites this paper
• B cell-derived IL-4 acts on podocytes to induce proteinuria and foot process effacement

  2021cites this paper
• Immunological Impact of a Gluten-Free Dairy-Free Diet in Children With Kidney Disease: A Feasibility Study

  2021cites this paper
• Seven novel podocyte autoantibodies were identified to diagnosis a new disease subgroup-autoimmune Podocytopathies.

  2021cites this paper
• Hsa_circ_0001461 as a novel biomarker in patients with primary focal segmental glomerulosclerosis

  2021cites this paper
• Rituximab or plasmapheresis for prevention of recurrent focal segmental glomerulosclerosis after kidney transplantation: A systematic review and meta-analysis

  2021cites this paper
• Urinary Protein and Peptide Markers in Chronic Kidney Disease

  2021cites this paper
• Re‐transplantation in pediatric patients with failure of primary transplant due to recurrent focal segmental glomerulosclerosis: A pediatric nephrology research consortium study

  2021cites this paper
• Apheresis in Adult With Refractory Idiopathic Nephrotic Syndrome on Native Kidneys

  2021cites this paper
• A mouse model of prenatal exposure to Interleukin-6 to study the developmental origin of health and disease

  2021cites this paper
• CyTOF-Enabled Analysis Identifies Class-Switched B Cells as the Main Lymphocyte Subset Associated With Disease Relapse in Children With Idiopathic Nephrotic Syndrome

  2021cites this paper
• Novel diagnostic and therapeutic techniques reveal changed metabolic profiles in recurrent focal segmental glomerulosclerosis

  2020cites this paper
• Recurrent Glomerulonephritis in the Kidney Allograft

  2020cites this paper
• Children's Mercy Kansas City

  2020cites this paper
• [The balance of proinflammatory cytokines and Treg cells in chronic glomerulonephritis].

  2020cites this paper
• Autoimmunity in Focal Segmental Glomerulosclerosis: A Long-Standing Yet Elusive Association

  2020cites this paper
• Collapsing focal segmental sclerosis in an HIV‐negative patient

  2020cites this paper
• Recurrent glomerulonephritis after renal transplantation

  2020cites this paper
• Kidney transplantation for primary glomerulonephritis: Recurrence risk and graft outcomes with related versus unrelated donors.

  2020cites this paper
• Update on Recurrent Focal Segmental Glomerulosclerosis in Kidney Transplantation

  2020cites this paper
• Combination of High-Dose Intravenous Cyclosporine and Plasma Exchange Treatment Is Effective in Post-Transplant Recurrent Focal Segmental Glomerulosclerosis: Results of Case Series.

  2020cites this paper
• Heat shock protein 90 and NFkB levels in serum and urine in patients with chronic glomerulonephritis

  2020cites this paper
• Podocytopathies

  2020cites this paper
• Several reasons for the development of proteinuria in nephrotic syndrome

  2020cites this paper
• Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children.

  2020cites this paper
• Extracorporeal Therapies in the Treatment of Focal Segmental Glomerulosclerosis

  2020cites this paper
• Annals of Immunology & Immunotherapy

  2020cites this paper
• LPS-Treated Podocytes Polarize Naive CD4+ T Cells into Th17 and Treg Cells

  2020cites this paper
• Recurrent Glomerulonephritis after Renal Transplantation: The Clinical Problem

  2020cites this paper
• Angiotensin II receptor 1 antibodies associate with post-transplant focal segmental glomerulosclerosis and proteinuria

  2020cites this paper
• Further Evidence That the Soluble Urokinase Plasminogen Activator Receptor Does Not Directly Injure Mice or Human Podocytes

  2020cites this paper
• Disease Recurrence—The Sword of Damocles in Kidney Transplantation for Primary Focal Segmental Glomerulosclerosis

  2019cites this paper
• TRPC channels: Regulation, dysregulation and contributions to chronic kidney disease.

  2019cites this paper
• Genotypic and Phenotypic Features of Both NPHS1 and NPHS2 Genes in Infantile Nephrotic Syndrome and Prognostic Effect of E117K Polymorphism in NPHS1 Gene

  2019influential citation
• Nephrotic syndrome in a dish: recent developments in modeling in vitro

  2019cites this paper
• The elusive podocyte crossmatch for recurrent focal segmental glomerulosclerosis.

  2019cites this paper
• Clinical Outcomes of Prophylactic and Therapeutic Plasmapheresis in Adult Deceased-Donor Kidney Transplant Recipients With Primary Focal Segmental Glomerulosclerosis.

  2019cites this paper
• Successful Treatment of Focal Segmental Glomerulosclerosis Recurrence in a Second Kidney Transplant Patient: A Case Report.

  2019cites this paper
• Pathogenesis of Minimal Change Nephrotic Syndrome: A Review of the Underlying Molecular Mechanisms

  2019cites this paper
• Early Course of the Patient With a Kidney Transplant

  2019cites this paper
• Circulating Permeability Factors in Idiopathic Nephrotic Syndrome

  2019cites this paper
• Induction of steady-state glomeruloid sphere by self-assembly from human embryonic kidney cells.

  2019cites this paper
• Assessment of increased glomerular permeability associated with recurrent focal segmental glomerulosclerosis using an in vitro model of the glomerular filtration barrier

  2019cites this paper
• 1 The Role of Humoral and Cell-Mediated Adaptive Immune Response

  2019cites this paper
• Identification of glomerular and podocyte-specific genes and pathways activated by sera of patients with focal segmental glomerulosclerosis

  2019cites this paper
• [Idiopathic nephrotic syndrome: une Arlésienne?]

  2019cites this paper
• Diagnostic and Prognostic Value of Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) in Focal Segmental Glomerulosclerosis and Impact of Detection Method

  2019cites this paper
• Post-transplant recurrence of steroid resistant nephrotic syndrome in children: the Italian experience

  2019cites this paper
• Immunoadsorption in nephrotic syndrome: Where are we now and where are we going from here?

  2019cites this paper
• Focal Segmental Glomerulosclerosis, Adult

  2019cites this paper
• Molecular stratification of idiopathic nephrotic syndrome

  2019cites this paper
• Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

  2019cites this paper
• Causes and Pathophysiology of Nephrotic Syndrome in Childhood

  2019cites this paper
• Genetics of Childhood Steroid Sensitive Nephrotic Syndrome: An Update

  2019cites this paper
• Physiopathologie des syndromes néphrotiques idiopathiques

  2019cites this paper
• Monogenic Causes of Proteinuria in Children

  2018cites this paper
• 6 Focal Segmental Glomerulosclerosis ( FSGS ) Recurrence in Kidney Allograft Recipients

  2018cites this paper
• Therapeutic apheresis in immunocomplex nephritis: A case report of a successful treatment.

  2018cites this paper
• Recurrence of nephrotic syndrome following kidney transplantation is associated with initial native kidney biopsy findings

  2018cites this paper
• Plasmapheresis and Total Plasma Exchange in the PICU

  2018cites this paper